Effects of Concomitant Administration of BMS-986195 on the Single-dose Pharmacokinetics of Methotrexate in Healthy Participants

Trial Profile

Effects of Concomitant Administration of BMS-986195 on the Single-dose Pharmacokinetics of Methotrexate in Healthy Participants

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 02 May 2017

At a glance

  • Drugs BMS 986195 (Primary) ; Folinic acid; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 02 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top